- Home
- CVAC vs DLY Comparison
CVAC vs DLY Comparison
Compare CVAC & DLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- DLY
- Stock Information
- Founded
- CVAC 2000
- DLY 2019
- Country
- CVAC Germany
- DLY United States
- Employees
- CVAC N/A
- DLY N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- DLY Investment Managers
- Sector
- CVAC Health Care
- DLY Finance
- Exchange
- CVAC Nasdaq
- DLY Nasdaq
- Market Cap
- CVAC 818.8M
- DLY 790.9M
- IPO Year
- CVAC 2020
- DLY N/A
- Fundamental
- Price
- CVAC $2.77
- DLY $16.10
- Analyst Decision
- CVAC Hold
- DLY
- Analyst Count
- CVAC 3
- DLY 0
- Target Price
- CVAC $10.00
- DLY N/A
- AVG Volume (30 Days)
- CVAC 620.8K
- DLY 215.9K
- Earning Date
- CVAC 05-22-2025
- DLY 01-01-0001
- Dividend Yield
- CVAC N/A
- DLY 8.93%
- EPS Growth
- CVAC N/A
- DLY N/A
- EPS
- CVAC N/A
- DLY N/A
- Revenue
- CVAC $70,565,734.00
- DLY N/A
- Revenue This Year
- CVAC $742.57
- DLY N/A
- Revenue Next Year
- CVAC N/A
- DLY N/A
- P/E Ratio
- CVAC N/A
- DLY N/A
- Revenue Growth
- CVAC 75.11
- DLY N/A
- 52 Week Low
- CVAC $2.22
- DLY $13.26
- 52 Week High
- CVAC $5.28
- DLY $15.95
- Technical
- Relative Strength Index (RSI)
- CVAC 38.24
- DLY 47.40
- Support Level
- CVAC $2.78
- DLY $15.96
- Resistance Level
- CVAC $3.33
- DLY $16.20
- Average True Range (ATR)
- CVAC 0.15
- DLY 0.10
- MACD
- CVAC -0.00
- DLY -0.01
- Stochastic Oscillator
- CVAC 8.20
- DLY 51.85
About CVAC CureVac N.V.
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid, or mRNA. The company was founded in 2000 and had its initial public offering in August 2020. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and Covid vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About DLY DoubleLine Yield Opportunities Fund of Beneficial Interest
DoubleLine Yield Opportunities Fund is a diversified, limited-term, closed-end management investment company. Its investment objective is to seek a high level of total return, with an emphasis on current income. The company invests in debt securities and other income-producing investments of issuers anywhere in the world, including in emerging markets, and may invest in investments of any credit quality. Its investment portfolio comprises foreign corporate bonds, foreign government bonds, non-agency commercial mortgage-backed obligations, U.S. corporate bonds, collateralized loan obligations, and bank loans among other securities.